We’ve all played telephone. The game where information
passes from one player to the next until the end result is
unrecognizable. As a game, it’s funny. When treating rare
disease, it’s not. Drugs move down a chain of middlemen,
generating confusion and expense along the way. Patient
adherence suffers, quality of care diminishes, manufacturers
miss out on vital feedback and cost goes up. Imagine if you
could cut past all that. We did.
LOST IN TRANSITION
BUSINESS PROCESS OUTSOURCING FOR TODAY.